The holy grail of malaria prevention, a vaccine effective in preventing this devastating mosquito-borne parasitic disease, is one step closer to reality. The new GSK vaccine, RTS/S now called Mosquirix, provided significant albeit below-ideal levels of protection for infants and toddler, which will save thousands of lives.
